Beyond Air® Announces Participation at Upcoming Virtual Investor Conferences in March 2021

Beyond Air® Receives Grant for Up to $2.17 million from the Cystic Fibrosis Foundation to Advance the Clinical Development of Inhaled Nitric Oxide to Treat Nontuberculous Mycobacteria Pulmonary Disease

33rd Annual Roth Conference

Mar 15 – Mar 17, 2021

Oppenheimer 31st Annual Healthcare Conference

Mar 16, 2021 • 9:20 am EST